DVA
Stock Details
DVA is DaVita Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 110.86$. Average daily volumn in 3 months 687.51k. Market cap 8.93B
Stock symbol : DVA. Exchange : NYSE. Currency : USD Lastest price : 94.43$. Total volume : 742.26k. Market state POSTPOST Click reload if you want to check the lastest price on market!!!
DaVita Inc. (DVA)
Last Price
94.43$Change
0.18Volume
742.26k
| Previous Close | 94.25 |
| Open | 94.69 |
| Day Range | 92.84-94.98 |
| Bid | 92.50 x 900 |
| Ask | 94.70 x 900 |
| Volume | 742.26k |
| Average Volume | 687.51k |
| Market Cap | 8.93B |
| Beta | 1.13 |
| 52 Week Range | 92.63-136.48 |
| Trailing P/E | 11.16 |
| Foward P/E | 9.13 |
| Dividend (Yield %) | N/A |
| Ex-Dividend Date | N/A |
Financial Details
Organization
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient di... alysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Market Cap:
8.93BRevenue:
11.62BTotal Assets:
17.12BTotal Cash:
461.9M
News about "DaVita Inc."
Reasons to Retain DaVita (DVA) Stock in Your Portfolio For Now
Source from : Nasdaq - 20 hours ago
DaVita Inc. DVA is well poised for growth in the coming quarters, backed by strength in DaVita Kidney Care. A robust first-quarter 2022 performance, along with impressive overseas growth, is expected ...See details»
In sale-leaseback, DaVita unloads new Federal Way building for $94M
Source from : The Business Journals - 2 days ago
DaVita said the company would employ 1,300 people in Federal Way. Today, it says it has 950 team members across Washington state.See details»
DaVita Inc. (NYSE:DVA) Receives Consensus Rating of “Hold” from Analysts
Source from : Defense World - 6 days ago
DaVita Inc. (NYSE:DVA – Get Rating) has been given an average rating of “Hold” by the eight brokerages that are covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a ...See details»
DaVita Becomes Oversold (DVA)
Source from : Nasdaq - 2 days ago
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Wednesday, shares of DaVita Inc (Symbol: DVA) entered into oversold territory, hitting an RSI reading of 29.6, ...See details»
DaVita Inc. (NYSE:DVA) Expected to Post Quarterly Sales of $2.97 Billion
Source from : ETF Daily News - 13 days ago
Equities research analysts predict that DaVita Inc. (NYSE:DVA – Get Rating) will report $2.97 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have ...See details»
Analysts Anticipate DaVita Inc. (NYSE:DVA) Will Announce Earnings of $2.09 Per Share
Source from : Defense World - 13 days ago
Analysts forecast that DaVita Inc. (NYSE:DVA – Get Rating) will report earnings per share (EPS) of $2.09 for the current quarter, Zacks reports. Two analysts have issued estimates for DaVita’s ...See details»
DaVita Inc. (NYSE:DVA) Receives Consensus Recommendation of “Hold” from Brokerages
Source from : ETF Daily News - 6 days ago
DaVita Inc. (NYSE:DVA) Given Average Recommendation of “Hold” by Brokerages First Majestic Silver (TSE:FR) Given New C$12.00 Price Target at TD Securities Exchange Income (TSE:EIF) Upgraded to ...See details»
DaVita Inc. to Participate in the Bank of America Securities 2022 Healthcare Conference
Source from : Business Insider - 11 days ago
A magnifying glass. It indicates, "Click to perform a search". DENVER, May 9, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman ...See details»
DaVita Inc.: DaVita Faces Challenges in Q1 but Maintains its 2022 and Preliminary 2023 Outlook; No FVE Change
Source from : YAHOO!Finance - 12 days ago
Find the latest DaVita Inc. (DVA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»
DaVita Offers Stability During Market Volatility
Source from : Seeking Alpha - 9 days ago
One of those names is DaVita Inc. (NYSE:DVA). DaVita is one of those companies that provides a service/product which is not easily replaced, is regulated, and is required by those who need it.See details»
DaVita Inc. to Participate in the Bank of America...
Source from : Benzinga.com - 11 days ago
DaVita DVA is a comprehensive kidney care provider focused on transforming care to improve the quality of life for patients globally. The company is one of the largest providers of kidney care ...See details»
DaVita Honors Extraordinary Nurses with DAISY Awards
Source from : Business Insider - 10 days ago
To learn more about a career as a nephrology nurse, visit Careers.DaVita.com. About DaVita Inc. DaVita (NYSE: DVA) is a comprehensive kidney care provider focused on transforming care to improve ...See details»
DaVita Inc. 1st Quarter 2022 Results
Source from : Yahoo Finance - 13 days ago
DENVER, May 5, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a ...See details»
Rockwell Medical, Inc. (RMTI) CEO Russell Ellison on Q1 2022 Results - Earnings Call Transcript
Source from : Seeking Alpha - 4 days ago
DaVita Inc., which is a leading provider of kidney care in the U.S. with a market capitalization of approximately $10 billion. The amended supply agreement is designed to enable Rockwell Medical ...See details»